Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes

Similar documents
COMMISSION REGULATION (EU)

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Practical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings

GLP in the European Union Ecolabel detergents, GLP and accreditation

IMPORTANT DISCLAIMER. Note

1 OJ L 354, , p OJ L 80, , p. 19.

EFSA Statement regarding the EU assessment of glyphosate and the socalled

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz

EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS

Procedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human medicinal products

TERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY

DIRECTIVES. (Text with EEA relevance)

GLP Update and Hot Topics

MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings

EFSA s Catalogue of support initiatives during the lifecycle of applications for regulated products

EFSA s Catalogue of support initiatives during the life-cycle of applications for regulated products. European Food Safety Authority (EFSA)

Standard operating procedure

FoodDrinkEurope Position on GLP studies

EFSA PRE-SUBMISSION GUIDANCE FOR APPLICANTS INTENDING TO SUBMIT APPLICATIONS FOR AUTHORISATION OF HEALTH CLAIMS MADE ON FOODS

EFSA cross-cutting guidance lifecycle. European Food Safety Authority (EFSA), Daniela Maurici, Raquel Garcia Matas, Andrea Gervelmeyer

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015

Working Document prepared by the Commission services - does not prejudice the Commission's final decision 3/2/2014 COMMISSION STAFF WORKING DOCUMENT

VOLUME 6A Procedures for marketing authorisation

Delegations will find attached document D051559/03.

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893

Standard Operating Procedures (SOP) Research and Development Office

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

CHAPTER 3. September 2007

Guideline on influenza vaccines submission and procedural requirements

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA

CHAPTER 3. Union Referral Procedures MAY 2014

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 30 April 2012

Standard operating procedure

1 OJ L 354, , p OJ L 80, , p. 19.

2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

COMMISSION REGULATION (EU) / of XXX

The Nutrition (Amendment) (EU Exit) Regulations 2018

Follow-up of the food additive re-evaluation programme by the European Commission

EUROPEAN COMMISSION. Modus Operandi for the management of new food safety incidents with a potential for extension involving a chemical substance

(Legislative acts) REGULATIONS

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015

Procedural advice on the submission of variations for annual update of human influenza inactivated vaccines applications in the centralised procedure

Comparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome

European Union legislation on Food additives, Food enzymes, Extractions solvents and Food flavourings

COMMISSION DELEGATED REGULATION (EU) /... of XXX

Survey results - Analysis of higher tier studies submitted without testing proposals

SOP-QA-30 V Scope

IAF Mandatory Document. Requirements for the Migration to ISO 45001:2018 from OHSAS 18001:2007 (IAF MD 21:2018)

Clinical Trials in Third Countries

COMMISSION REGULATION (EU) / of XXX. authorising certain health claims made on foods and referring to children's development and health

COMMISSION DELEGATED REGULATION (EU) /... of XXX

Consultation Strategy. Impact Assessment on an initiative to limit industrial trans fats intakes in the EU

Adopted by CVMP 10 March Date for coming into effect 1 July Revised draft guideline agreed by Immunologicals Working Party 22 June 2017

C 178/2 Official Journal of the European Union

All member States were represented, except Bulgaria and Czech Republic

Council of the European Union Brussels, 24 March 2015 (OR. en)

Guideline on good pharmacovigilance practices (GVP)

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food

Decentralised Procedure. Public Assessment Report. Lorazepam-neuraxpharm 1/ 2,5 mg Schmelztabletten. Lorazepam DE/H/4558/ /DC

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

CARIBX (UK) LIMITED. Environmental, Health and Safety Management System. Revision: 00 APRIL 2011

ECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate

Delegations will find attached document D042445/02.

European Food Safety Authority (EFSA)

EU Regulatory Requirements Update, the latest news and developments. Hans-Heiner Junker TÜV SÜD Product Service GmbH October 2013

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

The Nutrition and Health Claims Regulation

An example of intersectoral collaboration: the EU model. European Commission Health and Consumers Directorate-General (DG SANCO)

APPROVED: 30 March 2015 PUBLISHED: 15 April 2015

Import Risk Assessment of Plant Pests The EU Situation

4. Considerations for streamlining the prequalification procedure on the basis of enhanced assistance by NRAs 328

Action plan for improving the peer review process. European Food Safety Authority (EFSA)

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section General Food Law)

Accreditation Criteria

Guideline on the processing of renewals in the centralised procedure

REGULATION (EC) No.141/2000

Topics covered by the talk

Delegations will find attached document D048379/05.

REASONED OPINION. European Food Safety Authority 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Quality Assurance Policy. for the. Procurement of HIV Point-of-Care Technology. under the UNITAID Grant

Preparatory work to support the re-evaluation of technological feed additives

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE

SUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD ON DECEMBER 2009 IN BRUSSELS (Section Animal Nutrition)

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Guidance on the GLP Requirements for Peer Review of Histopathology Advisory Document

Singapore s Progress on GLP and MAD

Decentralised Procedure. Public Assessment Report. ALGOTRA 37.5 mg/325 mg überzogene Tabletten Tramadol/Paracetamol DE/H/3688/001/DC

COMMISSION REGULATION (EU) / of XXX

Meeting of the EU GLP Working Group, February GLP requirements in EU legislation and guidance medical devices

Darwin Marine Supply Base HSEQ Quality Management Plan

COMMISSION REGULATION (EU) / of XXX

Title: Handling of a request for accelerated assessment of initial marketing authorisation applications (human use)

Transcription:

Scope To describe the procedure for EFSA to request on a yearly or ad-hoc basis the performance of GLP studies audits by the GLP Monitoring Authorities. To lay down criteria for the selection of the GLP studies for annual audits and the definition of the follow up actions to be taken by EFSA. This SOP applies to all GLP studies received by as part of a technical dossier of an application for regulated products and for which audits may be requested within EFSA. Special Requirements This procedure is a controlled document maintained by Quality Management. It may not be deleted without comparable controls. Responsibilities General responsibilities: - EFSA is responsible for the selection of the studies to be audited; - GLP Monitoring Authorities under whose responsibility the test facility falls is responsible for the study audits; - The EFSA GLP coordinator is responsible to store all related documents, including correspondence, under the DMS. Specific responsibilities - Part I - EFSA Yearly GLP Studies Audit Programme: 0.1. Selection of the studies for audit purpose ; 0.2. Preparation, proposal and approval of the EFSA Yearly GLP Study Audit Programme ; 0.3. Request for GLP study audits HoD REPRO and ; 0.4. Audits outcome and definition of follow-up actions with the collaboration of the relevant REPRO Units; 0.5. Reporting with the collaboration of the relevant REPRO Units. Specific responsibilities Part II EFSA Ad-hoc GLP studies audit 0.1. Proposal of the GLP studies for an ad-hoc audit Relevant REPRO Units; 0.2. Approval of the GLP studies for an ad-hoc audit HoD REPRO; 0.3. Preparation of the audit request ; 0.4. Audits report management and definition of follow-up actions - Page 1 of 7

Abbreviations and definitions with the collaboration of the relevant REPRO Units; 0.5. Reporting with the collaboration of the relevant REPRO Units. Applicant Area responsible Assessors CIRCABC DG GROWTH DMS EC EU GLP GLP coordinator GLP Monitoring Authority (MA) GLP studies HoD-REPRO HoU OECD QA QM REPRO SO SOP Study audit Applications Desk Unit Applicant of an authorisation or approval The responsible for an area of regulated products Scientific Committee/Panel/Working Group/Network/EFSA Staff/Rapporteur Member State Communication and Information Resource Centre for Administrations, Businesses and Citizens DG Internal Market, Industry, Entrepreneurship and SMEs of the EC Document Management System European Commission European Union Good Laboratory Practice is a quality system concerned with the organisational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported The scientific officer responsible for the coordination of the GLP activities A body established within a Member State or an OECD Country with responsibility for monitoring the GLP compliance of test facilities within its territories. Studies performed in compliance with the GLP principles Head of REPRO Department Head of Unit Organisation for Economic Co-operation and Development Quality assurance programme means a defined system, including personnel, which is independent of study conduct and is designed to assure test facility management of compliance with these principles of GLP Quality Manager Scientific Evaluation of Regulated Products Scientific Officer Standard Operating Procedure On-site assessment of the compliance with the OECD GLP principles Page 2 of 7

Study audit report Procedure Part I Step 1 as adopted by the EU, performed by officials of GLP Monitoring Authorities or authorities found equivalent under a Mutual Recognition Agreement. In the context of this SOP, two types of study audits are distinguished: - a surveillance study audit is an audit that is part of a planned routine GLP inspection; - a triggered study audit is a special audit triggered by specific concerns identified upon submission of an application. The reasons why the triggered study audit has been requested shall be mentioned. In the exceptional case in which the test facility is not part of an EU monitoring programme, a general GLP Inspection covering general GLP compliance could be carried out in accordance with the OECD Environmental Health and Safety ations (ENV/JM/MONO(2000)3). Series on Principles of Good Laboratory Practice and Compliance Monitoring. Requesting and Carrying Out Inspections and Study Audits in Another Country. Report on the compliance of the audited studies with the EU GLP principles prepared by the official representing the GLP Monitoring Authority. The term Study audit report used in this SOP refers to the Inspection report as specified in Annex I, Part B of Directive 2004/9/EC. EFSA Yearly GLP Studies Audit Programme Previous SOPs in the process: SOP_001_S Receiving a request 1.0 Selection of the studies for audit purpose 1.1. By 30 th April of each year, the GLP coordinator will propose the list of studies to be part of the EFSA Yearly GLP Studies Audit Programme. For the selected studies a surveillance study audit will be requested; 1.2. The GLP coordinator, in collaboration with the scientific officers, will select up to 20 studies to be part of EFSA Yearly GLP Studies Audit Programme. The selected studies shall comply at the same time with all three selection criteria: 1. The study is part of an application for regulated products for which EFSA has published an opinion/conclusion in the past year. 2. The study report includes a statement from the study director that Page 3 of 7

Step 2 Step 3 HoD REPRO Step 4 and the relevant REPRO Units the study was conducted in compliance to the GLP principles and a statement of Quality Assurance; 3. The study has been performed in a test facility for which the relevant GLP Monitoring Authority has scheduled an inspection according to the planning published on the European Commission portal (CIRCABC). 1.3. Studies from all REPRO Units are considered for inclusion in the Yearly GLP Studies Audit Programme, independently of the legal requirement of the sectorial legislations. If possible, at least one study for each scientific area for which EFSA has published an opinion/conclusion in the past year shall be selected. 2.0 Preparation, proposal and approval of the EFSA Yearly GLP Studies Audit Programme 2.1. The GLP coordinator will draft the list of the GLP studies selected to be included into the EFSA Yearly GLP Studies Audit Programme; 2.2. HoU will send the final version of the EFSA Yearly GLP Studies Audit Programme to the HoD REPRO for approval. On approval of the programme, the audit will be launched. 2.3. The EFSA Yearly GLP Studies Audit Programme will be distributed for information, to the REPRO HoUs, EC DG GROWTH and EC DG SANTE. 3.0 Request for GLP Study Audits 3.1 The GLP coordinator will prepare all the letters to be sent to the responsible GLP Monitoring Authorities, for the HoD REPRO s signature; 3.2 The REPRO HoD will sign all letters; 3.3 The GLP coordinator will send the signed letters and the full study reports to the respective Monitoring Authorities with a copy to the EC DG GROWTH; 3.4 The yearly audit will be initiated. 4.0 Audits outcome and definition of follow up actions Page 4 of 7

Step 5 and the relevant REPRO Units 4.1. Upon reception of the study audit reports, the GLP coordinator shall distribute the audit reports to the concerned REPRO Units; 4.2 Two types of non-compliances can be reported: a non-compliance of administrative nature and a non-compliance of scientific nature. In case the outcome of the study report reveals an administrative non-compliance, the relevant unit is informed but no further action is required. 4.3. If the GLP compliance is not a legal requirement of the relevant sectorial legislation, the outcome of the study audit report revealing a scientific non-compliance will be considered on a case-by-case basis; 4.4. If the GLP compliance is a legal requirement of the sectorial legislations, the REPRO Scientific Unit will judge on the impact of the study audit report revealing a scientific non-compliance on the outcome of the risk assessment; when the scientific non-compliance has no impact on the outcome of the risk assessment, an argumentation will be provided by the REPRO scientific Unit in a Note to the file ; when the scientific non-compliance has a possible impact on the outcome of the risk assessment, an argumentation will be provided by the REPRO scientific Unit in a Note to the file and a formal request will be addressed to the responsible scientific panel/scientific staff to initiate a self-task to reopen the scientific output. 4.5. The REPRO Units will inform the GLP Coordinator about the followup actions in the case of scientific non-compliances. 4.6. The HoU will inform the applicant, the EC DG SANTE, the EC DG GROWTH and the Member States GLP Monitoring Authorities about the follow-up/corrective actions. 4.7. In case the study audit report mentions any findings impacting on the integrity of the study, the HoU- will inform the GLP Monitoring Authorities, EC DG GROWTH and EC DG SANTE of the way these findings have been taken into account during the evaluation. 5.0 Reporting 5.1. A yearly report will be developed by the GLP Coordinator including: the description of the procedure followed to implement the EFSA Yearly GLP Studies Audit Programme, the description of the studies considered, the outcome of the audit programme and the actions taken. Page 5 of 7

5.2. The yearly report shall be finalised within one month after reception of all the audit reports and distributed to all REPRO HoUs with copy to the Quality Manager. Procedure Part II Step 1 Relevant REPRO Units Step 2 HoD REPRO Step 3 EFSA Ad-hoc GLP studies audit 1.0 Proposal of the GLP studies for ad-hoc audit 1.1 In case of justifiable reason, a REPRO Unit managing applications for regulated products can request an ad-hoc GLP audit of a study received as part of an application and declared as GLP compliant by the applicant; 1.2 For the study selected for ad-hoc GLP audit, a triggered study audit will be requested; 1.3 The study report shall include a statement from the study director that the study was conducted according to the GLP principles and a statement of Quality Assurance; 1.4 Only studies that are part of an on-going risk assessment or assessment still to be started can be selected for an ad hoc GLP audit and the clock stop mechanism cannot be used having as reason awaiting the outcome of the audit report; 1.5 The HoU of the individual Units will send the proposed study for adhoc GLP audit to the GLP Coordinator, including the justifiable reason and the documentation. 2.0 Approval of the GLP studies ad-hoc audit 2.1. HoU will immediately send the proposal including the justifiable reason and the documentation to the HoD REPRO for approval. On approval of the request, the ad-hoc GLP study audit will be launched. 2.2. The GLP coordinator will inform the applicant that the study has been selected for an ad-hoc GLP audit. 3.0 Preparation of the ad-hoc GLP study audit request 3.1 The GLP coordinator will prepare a letter indicating the justifiable reasons for requesting an ad-hoc GLP study audit to the responsible GLP Monitoring Authorities, with a copy to the EC DG GROWTH. The letter is to be signed by the HoD REPRO; 3.2 The GLP coordinator will send the signed letter along with the full Page 6 of 7

Step 4 and the relevant RERPO Units Step 5 and the relevant RERPO Units study reports to the relevant Monitoring Authorities in order to initiate the audit. 4.0 Audits report management and definition of follow-up actions 4.1. Upon reception of the study audit reports, the GLP coordinator shall distribute the audit reports to the concerned REPRO Units; 4.2. If the outcome of the GLP study audit report is revealing a noncompliance, the relevant REPRO Unit shall decide on the implications for the risk assessment and take the appropriate measures during the risk assessment process; 4.3. The REPRO Units will inform the GLP Coordinator about the follow-up/corrective actions up to two months after the reception of the audit report. 4.4. HoU will inform the applicant, the EC DG GROWTH and the Member States GLP Monitoring Authorities about the follow-up/corrective actions. 4.5. In case the study audit report mentions any findings impacting on the integrity of the study, the HoU- will inform the GLP Monitoring Authorities, EC DG GROWTH and EC DG SANTE of the way these findings have been taken into account during the evaluation. 5.0 Reporting 5.1. A yearly report will be developed by the GLP Coordinator including: the description of the of the procedure followed to implement the EFSA Yearly GLP Studies Audit Programme, the description of the studies considered, the outcome of the audit programme and the actions taken; 5.2. The yearly report shall be finalised together with the report of the EFSA yearly GLP Audit Programme and be distributed to the REPRO HoUs with copy to Quality Manager. Following SOPs in the process: SOP_007_S Documenting the scientific risk assessment process Page 7 of 7